Pricing Log in Create free account

Cingulate Inc. (CING) vs OS Therapies Incorporated (OSTX)

Cingulate Inc. and OS Therapies Incorporated are both Biotechnology companies. Cingulate Inc. and OS Therapies Incorporated are of similar size ($66.0M and $63.8M). Across the 7 metrics below, OS Therapies Incorporated leads on 4 and Cingulate Inc. on 3.

Valuation

Metric CING OSTX Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.43 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (82.91%) (82.58%) (33.15%)
Free cash flow yield (36.67%) (31.98%) (25.50%)

Profitability

Metric CING OSTX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (198.74%) 1,129.52% (56.36%)
Return on assets (123.76%) (389.65%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CING OSTX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 56.47% 23.32% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CING OSTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.50 0.18 4.72
Net debt to EBITDA 0.51 0.01 0.96

Dividend

Metric CING OSTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CING OSTX Biotechnology median
Market cap 63.84m 66.00m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack